REFERENCES
  1. Huang R, Ning H, Shen M, Li J, Zhang J, Chen X. Probiotics for the Treatment of Atopic Dermatitis in Children: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Front Cell Infect Microbiol . 2017;7:392. Published 2017 Sep 6. doi:10.3389/fcimb.2017.00392
  2. Nutten S. Atopic dermatitis: global epidemiology and risk factors.Ann Nutr Metab. 2015;66 Suppl 1:8-16. doi:10.1159/000370220
  3. Gabriel, M.T., Lim, H.G., Gulmatico-Flores, et al . Guidelines for the management of atopic dermatitis: a literature review and consensus statement of the Philippine Dermatological Society. J Phil Dermatol Soc . 2020; 35-58.
  4. Chen L, Ni Y, Wu X, Chen G. Probiotics for the prevention of atopic dermatitis in infants from different geographic regions: a systematic review and Meta-analysis. J Dermatolog Treat.2022;33(7):2931-2939. doi:10.1080/09546634.2022.2091101
  5. Arkwright PD, David TJ. Intradermal administration of a killed Mycobacterium vaccae suspension (SRL 172) is associated with improvement in atopic dermatitis in children with moderate-to-severe disease. J Allergy Clin Immunol . 2001;107(3):531-534. doi:10.1067/mai.2001.113081
  6. Arkwright PD, David TJ. Effect of Mycobacterium vaccae on atopic dermatitis in children of different ages. Br J Dermatol . 2003;149(5):1029-1034. doi:10.1111/j.1365-2133.2003.05557.x
  7. Berth-Jones J, Arkwright PD, Marasovic D, et al. Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial.Clin Exp Allergy. 2006;36(9):1115-1121. doi:10.1111/j.1365-2222.2006.02558.x
  8. Brothers S, Asher MI, Jaksic M, Stewart AW. Effect of a Mycobacterium vaccae derivative on paediatric atopic dermatitis: a randomized, controlled trial. Clin Exp Dermatol. 2009;34(7):770-775. doi:10.1111/j.1365-2230.2008.03153.x
  9. Bodemer C, Guillet G, Cambazard F, et al. Adjuvant treatment with the bacterial lysate (OM-85) improves management of atopic dermatitis: A randomized study. PLoS One. 2017;12(3):e0161555. Published 2017 Mar 23. doi:10.1371/journal.pone.0161555
  10. Yan DC, Hung CH, Sy LB, et al. A Randomized, Double-Blind, Placebo-Controlled Trial Assessing the Oral Administration of a Heat-Treated Lactobacillus paracasei  Supplement in Infants with Atopic Dermatitis Receiving Topical Corticosteroid Therapy. Skin Pharmacol Physiol. 2019;32(4):201-211. doi:10.1159/000499436
  11. Rather IA, Kim BC, Lew LC, et al. Oral Administration of Live and Dead Cells of Lactobacillus sakei proBio65 Alleviated Atopic Dermatitis in Children and Adolescents: a Randomized, Double-Blind, and Placebo-Controlled Study. Probiotics Antimicrob Proteins.2021;13(2):315-326. doi:10.1007/s12602-020-09654-7
  12. Jeong K, Kim M, Jeon SA, Kim YH, Lee S. A randomized trial of Lactobacillus rhamnosus IDCC 3201 tyndallizate (RHT3201) for treating atopic dermatitis. Pediatr Allergy Immunol. 2020;31(7):783-792. doi:10.1111/pai.13269
  13. D’Auria E, Panelli S, Lunardon L, et al. Rice flour fermented with Lactobacillus paracasei CBA L74 in the treatment of atopic dermatitis in infants: A randomized, double- blind, placebo- controlled trial.Pharmacol Res . 2021;163:105284. doi:10.1016/j.phrs.2020.105284
  14. Salminen S, Collado MC, Endo A, et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics [published correction appears in Nat Rev Gastroenterol Hepatol. 2021 Jun 15;:] [published correction appears in Nat Rev Gastroenterol Hepatol. 2022 Aug;19(8):551]. Nat Rev Gastroenterol Hepatol . 2021;18(9):649-667. doi:10.1038/s41575-021-00440-6
  15. Nataraj BH, Ali SA, Behare PV, Yadav H. Postbiotics-parabiotics: the new horizons in microbial biotherapy and functional foods.Microb Cell Fact . 2020;19(1):168. Published 2020 Aug 20. doi:10.1186/s12934-020-01426-w
  16. D’Auria E, Pilloni S, Beretta S, Paradiso L, Zuccotti G. Probiotics, prebiotics and postbiotics in atopic dermatitis. Biomedical Journal of Scientific & Technical Research . 2019;22(5). doi:10.26717/bjstr.2019.22.003804
  17. Hutton B, Salanti G, Caldwell DM, et al. The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations. Ann Intern Med . 2015;162(11):777-784. doi:10.7326/M14-2385
  18. Severity scoring of atopic dermatitis: the SCORAD index. Consensus Report of the European Task Force on Atopic Dermatitis.Dermatology . 1993;186(1):23-31. doi:10.1159/000247298
  19. Hanifin JM, Thurston M, Omoto M, Cherill R, Tofte SJ, Graeber M. The eczema area and severity index (EASI): assessment of reliability in atopic dermatitis. EASI Evaluator Group. Exp Dermatol.2001;10(1):11-18. doi:10.1034/j.1600-0625.2001.100102.x
  20. Stalder JF, Barbarot S, Wollenberg A, et al. Patient-Oriented SCORAD (PO-SCORAD): a new self-assessment scale in atopic dermatitis validated in Europe. Allergy. 2011;66(8):1114-1121. doi:10.1111/j.1398-9995.2011.02577.x
  21. Wolkerstorfer A, de Waard van der Spek FB, Glazenburg EJ, Mulder PG, Oranje AP. Scoring the severity of atopic dermatitis: three item severity score as a rough system for daily practice and as a pre-screening tool for studies. Acta Derm Venereol . 1999;79(5):356-359. doi:10.1080/000155599750010256
  22. Berth-Jones J. Six area, six sign atopic dermatitis (SASSAD) severity score: a simple system for monitoring disease activity in atopic dermatitis. Br J Dermatol. 1996;135 Suppl 48:25-30. doi:10.1111/j.1365-2133.1996.tb00706.x
  23. Tan-Lim CSC, Esteban-Ipac NAR, Mantaring JBV 3rd, et al. Comparative effectiveness of probiotic strains for the treatment of pediatric atopic dermatitis: A systematic review and network meta-analysis.Pediatr Allergy Immunol . 2021;32(1):124-136. doi:10.1111/pai.13305
  24. Tawfik GM, Dila KAS, Mohamed MYF, et al. A step by step guide for conducting a systematic review and meta-analysis with simulation data.Trop Med Health . 2019;47:46. Published 2019 Aug 1. doi:10.1186/s41182-019-0165-6
  25. Gamble C, Hollis S. Uncertainty method improved on best-worst case analysis in a binary meta-analysis. J Clin Epidemiol . 2005;58(6):579-588. doi:10.1016/j.jclinepi.2004.09.013
  26. Sterne JAC, Savović J, Page MJ, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ . 2019;366:l4898. Published 2019 Aug 28. doi:10.1136/bmj.l4898
  27. Li Y, Zhang B, Guo J, Cao Z, Shen M. The efficacy of probiotics supplementation for the treatment of atopic dermatitis in adults: a systematic review and meta-analysis. J Dermatolog Treat.2022;33(6):2800-2809. doi:10.1080/09546634.2022.2080170
  28. Higgins JP, Thomas J, Chandler J, et al. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (updated February 2022). Cochrane. 2022. Available from: www.training.cochrane.org/handbook.
  29. Wan X, Wang W, Liu J, Tong T. Estimating the sample mean and standard deviation from the sample size, median, range and/or interquartile range. BMC Med Res Methodol. 2014;14:135. Published 2014 Dec 19. doi:10.1186/1471-2288-14-135
  30. Puhan MA, Schünemann HJ, Murad MH, et al. A GRADE Working Group approach for rating the quality of treatment effect estimates from network meta-analysis [published correction appears in BMJ. 2015;350:h3326]. BMJ . 2014;349:g5630. Published 2014 Sep 24. doi:10.1136/bmj.g5630
  31. Kirjavainen PV, Salminen SJ, Isolauri E. Probiotic bacteria in the management of atopic disease: underscoring the importance of viability. J Pediatr Gastroenterol Nutr. 2003;36(2):223-227. doi:10.1097/00005176-200302000-00012
  32. Nakata J, Hirota T, Umemura H, et al. Additive effect of Lactobacillus acidophilus L-92 on children with atopic dermatitis concomitant with food allergy. Asia Pac Allergy. 2019;9(2):e18. Published 2019 Apr 22. doi:10.5415/apallergy.2019.9.e18
  33. Schram ME, Spuls PI, Leeflang MM, Lindeboom R, Bos JD, Schmitt J. EASI, (objective) SCORAD and POEM for atopic eczema: responsiveness and minimal clinically important difference. Allergy . 2012;67(1):99-106. doi:10.1111/j.1398-9995.2011.02719.x
  34. Hajjaj FM, Salek MS, Basra MK, Finlay AY. Non-clinical influences on clinical decision-making: a major challenge to evidence-based practice. J R Soc Med . 2010;103(5):178-187. doi:10.1258/jrsm.2010.100104
  35. Vinderola G, Sanders ME, Salminen S, Szajewska H. Postbiotics: The concept and their use in healthy populations. Front Nutr . 2022;9:1002213. Published 2022 Dec 9. doi:10.3389/fnut.2022.1002213